BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 12195093)

  • 21. Myocardial viability in chronic ischemic heart disease: comparison of delayed-enhancement magnetic resonance imaging with 99mTc-sestamibi and 18F-fluorodeoxyglucose single-photon emission computed tomography.
    Liu Q; Zhao S; Yan C; Lu M; Jiang S; Zhang Y; Li S; Liu Y; Yang M; He Z
    Nucl Med Commun; 2009 Aug; 30(8):610-6. PubMed ID: 19491715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phantom studies for estimation of defect size on cardiac (18)F SPECT and PET: implications for myocardial viability assessment.
    Matsunari I; Yoneyama T; Kanayama S; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Tonami N; Hisada K
    J Nucl Med; 2001 Oct; 42(10):1579-85. PubMed ID: 11585876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.
    Yoshinaga K; Katoh C; Noriyasu K; Yamada S; Ito Y; Kuge Y; Kawai Y; Kohya T; Kitabatake A; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):882-90. PubMed ID: 12111128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
    Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial changes in glucose-loaded 18F-fluoro-2-deoxyglucose positron emission tomography, 99mTc-tetrofosmin and 123I-beta-methyl-p-iodophenyl-penta-decanoic acid myocardial single-photon emission computed tomography images in patients with anterior acute myocardial infarction.
    Fukuoka R; Horita Y; Namura M; Ikeda M; Terai H; Tama N; Takagi T; Bunko H
    Circ J; 2013; 77(1):137-45. PubMed ID: 23037521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of myocardial perfusion and viability using simultaneous 99mTc-tetrofosmin--FDG collimated SPECT.
    Fukuchi K; Katafuchi T; Fukushima K; Shimotsu Y; Toba M; Hayashida K; Takamiya M; Ishida Y
    J Nucl Med; 2000 Aug; 41(8):1318-23. PubMed ID: 10945521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
    Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
    J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.
    Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Tonami N; Hisada K
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):195-202. PubMed ID: 15449050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT.
    Slart RH; Bax JJ; Sluiter WJ; van Veldhuisen DJ; Jager PL
    J Nucl Cardiol; 2004; 11(6):689-96. PubMed ID: 15592192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [18F]Fluorodeoxyglucose as a memory marker of transient myocardial ischaemia.
    Abbott BG; Liu YH; Arrighi JA
    Nucl Med Commun; 2007 Feb; 28(2):89-94. PubMed ID: 17198348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
    Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y
    Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of dual-isotope coincidence/single-photon imaging of the myocardium.
    Di Bella EV; Kadrmas DJ; Christian PE
    J Nucl Med; 2001 Jun; 42(6):944-50. PubMed ID: 11390561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.
    Rischpler C; Langwieser N; Souvatzoglou M; Batrice A; van Marwick S; Snajberk J; Ibrahim T; Laugwitz KL; Nekolla SG; Schwaiger M
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):661-9. PubMed ID: 25680385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography--usefulness in assessing myocardial viability.
    Kambara H; Nohara R; Tamaki N; Ono S; Konishi J; Kawai C
    Jpn Circ J; 1992 Jun; 56(6):608-13. PubMed ID: 1625366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.
    Chen EQ; MacIntyre WJ; Go RT; Brunken RC; Saha GB; Wong CY; Neumann DR; Cook SA; Khandekar SP
    J Nucl Med; 1997 Apr; 38(4):582-6. PubMed ID: 9098206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/ 18F-FDG PET.
    Nkoulou R; Pazhenkottil AP; Buechel RR; Husmann L; Valenta I; Herzog BA; Wolfrum M; Ghadri JR; Kaufmann PA
    Int J Cardiovasc Imaging; 2011 Jul; 27(6):913-21. PubMed ID: 20931288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac ⁹⁹mTc sestamibi SPECT and ¹⁸F FDG PET as viability markers in Takotsubo cardiomyopathy.
    Christensen TE; Bang LE; Holmvang L; Ghotbi AA; Lassen ML; Andersen F; Ihlemann N; Andersson H; Grande P; Kjaer A; Hasbak P
    Int J Cardiovasc Imaging; 2014 Oct; 30(7):1407-16. PubMed ID: 24852336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET-CT evaluation of 2-deoxy-2-[18F]fluoro-D-glucose myocardial uptake: effect of respiratory motion.
    Chin BB; Nakamoto Y; Kraitchman DL; Marshall L; Wahl R
    Mol Imaging Biol; 2003; 5(2):57-64. PubMed ID: 14499145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography.
    Wu YW; Tadamura E; Kanao S; Yamamuro M; Marui A; Komeda M; Toma M; Kimura T; Togashi K
    Int J Cardiovasc Imaging; 2007 Dec; 23(6):757-65. PubMed ID: 17364219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.